Beth Goldstein

Public Health Analyst, 505(B)(2) Team, Office of New Drugs (Ond), Office of New Drug Policy (Ondp) at Fda

Based in Silver Spring, United States

View on LinkedIn

7-day free trial · no credit card

Seniority

Staff

Department

Public Administration & Safety

Location

Silver Spring

Industry

Government Administration

Company size

17K

Contact information

Reveal Beth's email and phone

Direct contact data is gated. Sign up and reveal. You only pay for verified records.

Email

1 credit

b•••••••@fda.gov

Phone

5 credits

+1 ••• •••• ••••

You only pay for valid records. Bounced emails and disconnected numbers cost nothing.

Background

About Beth Goldstein

Public Health Analyst with almost 29 years of experience at the Food and Drug Administration (FDA). Preeminent experience and expertise in leading the 505(b)(2) new drug application regulatory program in the Center for Drug Evaluation and Research’s (CDER) Office of New Drugs (OND). Served as OND’s Associate Director for Regulatory Affairs under the OND Director and has vast additional experience in areas of regulatory affairs, regulatory policy, postmarketing commitments/requirements, strategic process development, and regulatory health project management. Proven leader with deep expertise in drug development and regulatory pathways, stakeholder engagement, and cross-functional team leadership. Adept at guiding sponsors and applicants through complex regulatory landscapes. Effective communicator, trainer, and mentor to both internal staff and external stakeholders.

Decision-makers

Other people at Fda

Browse the Fda team →

Build a list of verified contacts at Fda

Free for 7 days · 50 credits · no card · only pay for verified records.

Start free

Reach more buyers like Beth

250M+ professionals with verified email and phone. You only pay for records that actually verify.

7-day trial · no credit card · cancel anytime

Beth Goldstein Email & Phone Number @ Fda | Kipplo Discover